These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

104 related items for PubMed ID: 5643306

  • 1. Free and peptide hydroxyproline in chronic uremia.
    Dubovský J, Dubovská E, Pacovský V, Hrba J.
    Clin Chim Acta; 1968 Mar; 19(3):387-90. PubMed ID: 5643306
    [No Abstract] [Full Text] [Related]

  • 2. Distortions of bone cell metabolism in uremia and their cause.
    Nichols G, Flanagan B, Veer Jv.
    Arch Intern Med; 1969 Nov; 124(5):530-8. PubMed ID: 5345859
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Catabolism of free hydroxyproline in chronic uremia.
    Avioli LV, Scharp C, Birge SJ.
    Am J Physiol; 1969 Aug; 217(2):536-40. PubMed ID: 5799384
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Estimation of hydroxylysine in urine and serum of patients with chronic uremia.
    Dubovsky J, Geary WT, Chilcutt DA.
    Clin Chim Acta; 1977 Apr 01; 76(1):41-53. PubMed ID: 856503
    [Abstract] [Full Text] [Related]

  • 7. [Plasma hydroxyproline in chronic renal failure (author's transl)].
    Heidbreder E, Lüke F, Heidland A.
    Med Klin; 1976 Nov 05; 71(45):1945-51. PubMed ID: 995035
    [Abstract] [Full Text] [Related]

  • 8. [Chronic kidney failure and absorption of aminophenazone].
    Wagner K, Buder HW.
    Z Gesamte Inn Med; 1971 Nov 01; 26(21):Suppl:296-8. PubMed ID: 5149920
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The hydroxyproline content of plasma of patients with impaired renal function.
    Hart W, Duursma SA, Visser WJ, Njio LK.
    Clin Nephrol; 1975 Nov 01; 4(3):104-8. PubMed ID: 1183097
    [Abstract] [Full Text] [Related]

  • 12. [Studies of the metabolism of fibrinogen-I 125 in cases of chronic glomerulonephritis and pyelonephritis and in uremic patients treated by periodical hemodialysis].
    Huber W, Previato G, Bertoli M, Cancarini GC, Toigo G, Gasparotto ML, Romagnoli GF.
    G Clin Med; 1975 Nov 01; 56(11-12):431-44. PubMed ID: 1233337
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Catabolism and excretion of free hydroxyproline in infancy.
    Morrow G, Kivirikko KI, Prockop DJ.
    J Clin Endocrinol Metab; 1967 Oct 01; 27(10):1365-71. PubMed ID: 6050957
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Structural changes in the protein and carbohydrate components of glomerular basement membrane in aminonucleoside nephrosis.
    Kefalides NA, Forsell-Knott L.
    Biochim Biophys Acta; 1970 Mar 17; 203(1):62-6. PubMed ID: 5445680
    [No Abstract] [Full Text] [Related]

  • 19. The nature of vitamin D resistance in experimental uremia.
    Kimberg DV, Baerg RD, Gershon E.
    Arch Intern Med; 1970 Nov 17; 126(5):891-5. PubMed ID: 4319936
    [No Abstract] [Full Text] [Related]

  • 20. Acute effects of calcium infusion on hydroxyproline.
    Dubovský J, Hrba J, Pacovský V.
    Clin Chim Acta; 1967 Jul 17; 17(1):107-10. PubMed ID: 6036458
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.